What You Should Know:
- The Clinic by Cleveland Clinic, a leading provider of virtual second opinions (VSOs), announced the expansion of Cancer Concierge by Cleveland Clinic—a program connecting cancer patients across the U.S. with expert oncology subspecialists.
- The program, offered by The Clinic and its partner Amwell, expands on traditional VSOs by offering advanced subspecialty reviews, insight into innovative treatments and trials, cancer education content, and optional follow-up
Read More
Autonomize AI Raises $28M Series A to Scale Agentic AI for Healthcare and Life Sciences
What You Should Know:
- Autonomize AI, a pioneer in AI-driven healthcare solutions, today announced that it raised $28 million in a Series A funding, bringing total capital raised to $32 million to date.
- The round was led by Valtruis, The Cigna Group Ventures, Tau Ventures, and other strategic investors. Asset Management Ventures, ATX Venture Partners and Capital Factory are among the company’s existing investors who also participated.
Autonomize AI Secures Funding to Scale
Read More
Lumeris Taps Google Cloud to Address the 2 Billion Hour Gap in Primary Care
What You Should Know:
- Lumeris, a leader in healthcare technology and services, and Google Cloud today announced a partnership to improve access to high-quality primary care in the United States by building Lumeris’ Tom™ platform on Google Cloud technology.
- The collaboration targets a growing gap, where annual demand for care exceeds 2.5 billion hours, but less than 500 million hours are available, according to Lumeris estimates.
Lumeris and Google Cloud Redefine Scalable,
Read More
Corti Launches FactsR™ to Cut Clinical ”Note Bloat” by 65%
What You Should Know:
- Corti, the leading infrastructure layer for building clinical-grade AI in healthcare, today announced the launch of FactsR™, a breakthrough real-time agentic reasoning system for clinical consultations. Designed with ambient documentation in mind, FactsR™ reduces general purpose AI driven “note bloat” by 65 percent, keeping records precise, relevant, and tightly aligned with the actual clinical conversation.
- By minimizing post-visit edits and transforming
Read More
Novo Nordisk Amps Up Drug Discovery with Gefion AI Supercomputer
What You Should Know:
-DCAI today announced that Novo Nordisk has become a customer of the Gefion AI supercomputer.
- Through this agreement, Novo Nordisk will gain access to Gefion's unparalleled computational capabilities to process vast datasets, with a goal of transforming drug discovery and development as well as driving healthcare innovation.
AI-Powered Supercomputing Alliance to Advance Drug Discovery at Scale
In a landmark multiyear agreement, Novo Nordisk and Gefion have
Read More
The Future of RCM: Ensemble Deploys Cohere’s Agentic AI for Hospitals
What You Should Know:
- Ensemble, a leading provider of end-to-end revenue cycle management (RCM), has partnered with Cohere, a security-first enterprise AI company, to introduce the first fully integrated agentic AI platform for revenue cycle orchestration in healthcare.
- This collaboration merges Ensemble’s decade-long RCM expertise with Cohere’s enterprise-grade AI infrastructure to deliver faster, smarter, and more secure financial operations for hospitals and health
Read More
Nicoya Lifesciences Acquires Applied Photophysics to Accelerate Drug Discovery
What You Should Know:
- Nicoya Lifesciences, Inc., a leading provider of advanced biologics characterization tools for drug discovery and development, today announced its acquisition of Applied Photophysics, a UK-based provider of biophysical characterization instrumentation.
- Applied Photophysics, bringing a 50-year history of delivering established analytical methods and reliable instrumentation, will now operate as part of Nicoya.
Nicoya Expands Biopharmaceutical Analytics
Read More
Mission Bio Unveils Industry-First Single-Cell Genotype and Targeted Gene Expression Solution
What You Should Know:
- Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform to become the only commercial solution that delivers simultaneous genotype and targeted gene expression profiling from over 10,000 single cells.
- The assay, which can be leveraged for Phase 2 or 3 trials to home in on patients most likely to
Read More
Elation Health’s Note Assist AI Scribe Now Supports 12 New Languages
What You Should Know:
- Elation Health, the clinical-first technology company powering innovation in primary care, today announced a significant expansion of its AI-powered Note Assist product to now support 12 additional languages.
- With today’s update, clinicians can conduct patient visits in Chinese (Mandarin and Cantonese), German, French, Japanese, Korean, Russian, Portuguese, Tagalog, Hindi, Vietnamese, and Arabic, in addition to existing English and Spanish support.
Elation
Read More
Amperos Health Launches AI Biller for Healthcare Provider Claims Denials and Collections
What You Should Know:
- Today Amperos Health (Amperos) announces the launch of the world’s first multi-modal AI biller for healthcare providers, designed to combat denials and collect unpaid claims for revenue cycle management (RCM) teams.
- With teams drowning in manual tasks to just gather the information needed to work denials, Amperos stands alone with its multi-modal platform, putting its AI coworker Amanda to work across both calling and insurance portals.
Amperos Health:
Read More
